SYNBIP 2.0: epitopes mapping, sequence expansion and scaffolds discovery for synthetic binding protein innovation
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkae893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Yanlin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, No. 55 South Univer…. Hauptthemen laut MEDLINE: Databases, Protein, Epitope Mapping. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Chongqing, Technology Innovation and Application Demonstration Project of Chongqing, Entrepreneurship and Innovation Support Plan for Chinese Overseas Students of Chongqing.
Abstract (Originalsprache)
Synthetic binding proteins (SBPs) represent a pivotal class of artificially engineered proteins, meticulously crafted to exhibit targeted binding properties and specific functions. Here, the SYNBIP database, a comprehensive resource for SBPs, has been significantly updated. These enhancements include (i) featuring 3D structures of 899 SBP–target complexes to illustrate the binding epitopes of SBPs, (ii) using the structures of SBPs in the monomer or complex forms with target proteins, their sequence space has been expanded five times to 12 025 by integrating a structure-based protein generation framework and a protein property prediction tool, (iii) offering detailed information on 78 473 newly identified SBP-like scaffolds from the RCSB Protein Data Bank, and an additional 16 401 555 ones from the AlphaFold Protein Structure Database, and (iv) the database is regularly updated, incorporating 153 new SBPs. Furthermore, the structural models of all SBPs have been enhanced through the application of the AlphaFold2, with their clinical statuses concurrently refreshed. Additionally, the design methods employed for each SBP are now prominently featured in the database. In sum, SYNBIP 2.0 is designed to provide researchers with essential SBP data, facilitating their innovation in research, diagnosis and therapy. SYNBIP 2.0 is now freely accessible at https://idrblab.org/synbip/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, No. 55 South University Town Road, High-tech Zone, Chongqing 401331, China.
- Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou, Zhejiang 310052, China.
- College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang 310058, China.
- School of Life Sciences, Chongqing University, No. 55 South University Town Road, High-tech Zone, Chongqing 401331, China.
ORCID-Profile: Feng Zhu, Weiwei Xue
Förderung
- Natural Science Foundation of Chongqing
- Technology Innovation and Application Demonstration Project of Chongqing
- Entrepreneurship and Innovation Support Plan for Chinese Overseas Students of Chongqing
Zitieren
APA
Li, Y., Li, F., Duan, Z., Liu, R., Jiao, W., Wu, H., Zhu, F., & Xue, W. (2025). SYNBIP 2.0: epitopes mapping, sequence expansion and scaffolds discovery for synthetic binding protein innovation. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae893
Vancouver
Li Y, Li F, Duan Z, Liu R, Jiao W, Wu H, et al. SYNBIP 2.0: epitopes mapping, sequence expansion and scaffolds discovery for synthetic binding protein innovation. Nucleic Acids Research. 2025. doi:10.1093/nar/gkae893
BibTeX
@article{Li2025,
author = {Li, Yanlin and Li, Fengcheng and Duan, Zixin and Liu, Ruihan and Jiao, Wantong and Wu, Haibo and Zhu, Feng and Xue, Weiwei},
title = {SYNBIP 2.0: epitopes mapping, sequence expansion and scaffolds discovery for synthetic binding protein innovation},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkae893}
}
EUVIMED